Page last updated: 2024-08-23

cephalexin and Dermatitis, Atopic

cephalexin has been researched along with Dermatitis, Atopic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Izadi, N; Leung, DYM1
Abrams, M; Huang, JT; Paller, AS; Rademaker, A; Tlougan, B1
Breton, JJ; Hirman, JW; Jorizzo, JL; Parish, LC; Scangarella, NE; Shawar, RM; White, SM1

Reviews

1 review(s) available for cephalexin and Dermatitis, Atopic

ArticleYear
Clinical approach to the patient with refractory atopic dermatitis.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018, Volume: 120, Issue:1

    Topics: Adrenal Cortex Hormones; Agammaglobulinemia; Cephalexin; Dermatitis, Atopic; Diagnosis, Differential; Drug Resistance; Exanthema; Humans; Immunoglobulins, Intravenous; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Patient Education as Topic; Practice Guidelines as Topic; Pruritus; Recurrence; Staphylococcal Infections

2018

Trials

2 trial(s) available for cephalexin and Dermatitis, Atopic

ArticleYear
Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.
    Pediatrics, 2009, Volume: 123, Issue:5

    Topics: Administration, Intranasal; Adolescent; Anti-Bacterial Agents; Body Surface Area; Cephalexin; Child; Child, Preschool; Community-Acquired Infections; Dermatitis, Atopic; Humans; Infant; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Severity of Illness Index; Sodium Hypochlorite; Staphylococcal Infections

2009
Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
    Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:6

    Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Cephalexin; Child; Child, Preschool; Dermatitis; Dermatitis, Atopic; Diterpenes; Double-Blind Method; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Methicillin Resistance; Middle Aged; Ointments; Skin Diseases, Infectious; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome

2006